BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 25864024)

  • 1. The landscape of precision cancer medicine clinical trials in the United States.
    Roper N; Stensland KD; Hendricks R; Galsky MD
    Cancer Treat Rev; 2015 May; 41(5):385-90. PubMed ID: 25864024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NCI-MATCH launch highlights new trial design in precision-medicine era.
    McNeil C
    J Natl Cancer Inst; 2015 Jul; 107(7):. PubMed ID: 26142446
    [No Abstract]   [Full Text] [Related]  

  • 3. Defining precision: The precision medicine initiative trials NCI-MPACT and NCI-MATCH.
    Coyne GO; Takebe N; Chen AP
    Curr Probl Cancer; 2017; 41(3):182-193. PubMed ID: 28372823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An overview of the NCI precision medicine trials-NCI MATCH and MPACT.
    Do K; O'Sullivan Coyne G; Chen AP
    Chin Clin Oncol; 2015 Sep; 4(3):31. PubMed ID: 26408298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of genomics on personalized cancer medicine.
    Arteaga CL; Baselga J
    Clin Cancer Res; 2012 Feb; 18(3):612-8. PubMed ID: 22298893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Personalized-medicine trials on the rise.
    Benowitz S
    J Natl Cancer Inst; 2012 Oct; 104(19):1425-6. PubMed ID: 23008496
    [No Abstract]   [Full Text] [Related]  

  • 7. American Society of Clinical Oncology Developing First Clinical Trial.
    Brower V
    J Natl Cancer Inst; 2015 Nov; 107(11):djv356. PubMed ID: 26538625
    [No Abstract]   [Full Text] [Related]  

  • 8. [Possibilities and limitations of stratified medicine based on biomarkers and targeted therapies in oncology].
    Ludwig WD
    Z Evid Fortbild Qual Gesundhwes; 2012; 106(1):11-22. PubMed ID: 22325103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Translating genomic discoveries to the clinic in pediatric oncology.
    Glade Bender J; Verma A; Schiffman JD
    Curr Opin Pediatr; 2015 Feb; 27(1):34-43. PubMed ID: 25502895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implementing precision medicine initiatives in the clinic: a new paradigm in drug development.
    Hollebecque A; Massard C; Soria JC
    Curr Opin Oncol; 2014 May; 26(3):340-6. PubMed ID: 24709975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Towards the goal of personalized medicine in gastric cancer--time to move beyond HER2 inhibition. Part II: Targeting gene mutations and gene amplifications and the angiogenesis pathway.
    Lee J; Ou SH
    Discov Med; 2013 Aug; 16(86):7-14. PubMed ID: 23911227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic research advances pancreatic cancer's early detection and treatment.
    Brower V
    J Natl Cancer Inst; 2015 Jul; 107(7):. PubMed ID: 26142448
    [No Abstract]   [Full Text] [Related]  

  • 13. Initiative for Molecular Profiling and Advanced Cancer Therapy and challenges in the implementation of precision medicine.
    Tsimberidou AM
    Curr Probl Cancer; 2017; 41(3):176-181. PubMed ID: 28410846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Intraclonal heterogeneity in tumors and its impact on precision medicine].
    Roux J; Gouzé JL; Hofman P
    Med Sci (Paris); 2015 Jan; 31(1):28-31. PubMed ID: 25658727
    [No Abstract]   [Full Text] [Related]  

  • 15. Personalizing oncology: perspectives and prospects.
    Mendelsohn J
    J Clin Oncol; 2013 May; 31(15):1904-11. PubMed ID: 23589547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Personalized oncology: recent advances and future challenges.
    Kalia M
    Metabolism; 2013 Jan; 62 Suppl 1():S11-4. PubMed ID: 22999010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Personalized oncology: genomic screening in phase 1.
    Tuxen IV; Jønson L; Santoni-Rugiu E; Hasselby JP; Nielsen FC; Lassen U
    APMIS; 2014 Aug; 122(8):723-33. PubMed ID: 25046202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time to adapt.
    Nature; 2010 Apr; 464(7293):1245-6. PubMed ID: 20428115
    [No Abstract]   [Full Text] [Related]  

  • 19. Precision medicine at Memorial Sloan Kettering Cancer Center: clinical next-generation sequencing enabling next-generation targeted therapy trials.
    Hyman DM; Solit DB; Arcila ME; Cheng DT; Sabbatini P; Baselga J; Berger MF; Ladanyi M
    Drug Discov Today; 2015 Dec; 20(12):1422-8. PubMed ID: 26320725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Introduction. Personalizing patient care with precision medicine.
    Wujcik D; Knoop T
    Semin Oncol Nurs; 2014 May; 30(2):81-3. PubMed ID: 24794081
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.